An update on your support of the Kaplan Cancer Research Fund Swedish Cancer Institute
|
|
- Silvester Shields
- 6 years ago
- Views:
Transcription
1 An update on your support of the Swedish Cancer Institute At Swedish, we re committed to offering our patients the newest, most innovative cancer treatment available. Through your support of the at the Swedish Cancer Institute, you re helping us make this vision a reality. Last year alone, supporters like you gave more than $1.3 million to research to SCI to help us prevent, treat and ultimately eliminate cancer. I m pleased to share this update on the pioneering research your support helps make possible. Over the past year, the Kaplan Fund sponsored several exciting research projects with the potential to yield better, more effective treatments for cancer. Together, we re bringing hope to our patients and their families, thank you. Developing treatments for patients with rare nerve sheath tumors In 2013, we first described the treatment of a patient with a malignant peripheral nerve sheath tumor (MPSNT), a rare form of cancer in the cells that cover nerves. This particular patient had a mutation in the BRAF gene (a gene that makes a protein called B-Raf) that s commonly associated with melanoma. We treated this patient with a BRAF inhibitor drug (a therapy that blocks cancer cells from growing) commonly used to treat melanoma, and the results were very encouraging. Henry G. Kaplan, M.D., medical oncologist and head of Kaplan Cancer Research Fund at the Swedish Cancer Institute Over the past year, our team has continued to work with Boston-based Foundation Medicine, a prominent genome evolution company, on a study to measure the incidence of BRAF mutations in patients with MPSNTs. To do this, we combined data from patients receiving their care at SCI with those evaluated at Foundation Medicine. We believe this will be the largest series of such patients ever reported, and we re hoping our work leads to clinical trials focused on inhibitor drugs for patients with MPSNTs. As part of this research we also described for the first time a new unique BRAF mutation that we ve found in a number of different tumor types. What excites us about this is that there are now drugs available that could inhibit the activity of this mutation, and one patient has shown a response already.
2 Swedish Cancer Institute Studies to treat breast cancer and prevent its recurrence We continue to be very active in studies related to breast cancer. Our success in this area is largely due to the Swedish Breast Registry. This robust database tracks detailed information on breast cancer patients spanning diagnosis and treatment, collecting 80 more data points per patient than a standard, nationally-mandated registry. This data is also longitudinal, meaning that it follows patients over the course of their lifetime, not just during their treatment. Thanks to supporters like you, we re able to maintain this invaluable resource by ensuring qualified staff are available to input new data and extract information designed to improve patient care and outcomes. The Swedish Breast Registry plays a central role in many of our research efforts, such as our ongoing project to compare the impact of early detection by mammography versus improvements in treatment. This is an extremely important issue, as there s a continuing international debate on who should have mammograms and how often they should have them. Over the past two decades there s been a considerable decrease in the breast cancer mortality rate, and it s difficult to determine what s played a larger role in this success mammography or better treatments. For some time now we ve explored the impact of mammography on the decreasing mortality rate. Now we re devoting considerable effort to examining how much new breast cancer treatments improve the health and outcomes for women with this disease. Over the past two years we ve published a number of studies on this topic, some of which looked at the general population and others that focused specifically on the elderly. We were recently approached by the Breast Cancer Research Foundation to study the course of metastatic breast cancer in our patients here at Swedish. Metastatic cancer is a cancer that s spread from the part of the body where it started (the primary site) to other parts of the body. Most breast cancer databases contain little information about this connection, but we re hopeful that the Swedish Breast Registry will allow us to explore it in greater depth. We also continue to participate in various clinical trials for breast cancer, including the highly innovative I-SPY 2 trial. This national research study brings new drug therapies to patients with breast cancer who urgently need them. Each participant is prescribed a series of medications before undergoing surgery. Their results are then analyzed throughout the course of the study, and advanced statistical methods are used to determine the likelihood that a given drug will help a particular patient. Results from early trial participants guide treatment for later participants, so researchers can determine quickly on whether a treatment is worth pursuing or not. When evidence indicates a high
3 Swedish Cancer Institute probability of success, the drug graduates to final-phase testing. So far, two of the drugs we ve introduced, veliparib and neratinib, have shown very promising results for patients. These results were published in the July 7, 2016 issue of The New England Journal of Medicine. We also continue to be very active in trials for vaccines that could prevent recurrence for breast cancer survivors. Kristine J. Rinn, M.D., medical oncologist at SCI, and I are still participating in trials related to NeuVax, a peptide vaccine aimed at preventing or delaying the recurrence of breast cancer in survivors who achieve remission after standard cancer treatment (e.g., surgery, radiation and chemotherapy). Our first study in this area, called Present, is complete and those results will soon be published. The data from the Present study has not shown NeuVax to be significantly beneficial for patients. However, our follow-up study to explore the effectiveness of NeuVax combined with Herceptin (also known as trastuzumab) is going well and enrolling many patients here and nationwide. Even though the Present study had limited success, there are reasons to believe that NeuVax may be synergistic with Herceptin, so we re hopeful that this study will yield more promising results. This past year, our in-house research group broadened to include the efforts of Erin D. Ellis, Donations to the help sustain vital research to improve patient care and outcomes. M.D., from medical oncology and Astrid D. Morris, M.D., from radiation oncology. Together, we ve explored the appropriate indications for performing radiation on the lymph nodes under the arm (called the axillary nodes) after breast surgery. With improvements in medical treatments for breast cancer, many physicians are now questioning how aggressively the axillary nodes should be treated with radiation and/or surgery. We ll be presenting two papers on this topic at the San Antonio Breast Cancer Symposium in December. Using stem cells to fight breast cancer Our team continues to work with Charles Cobbs, M.D., Parvinder Hothi, Ph.D., and the research group at the Swedish Neuroscience
4 Swedish Cancer Institute Institute (SNI) to study malignant stem cells in breast cancer. Stem cells are the cells from which all other cells eventually grow and differentiate into the various organs of our bodies. It s well understood that there are malignant stem cells, the mother cells that feed the continued growth of cancers. Some theories suggest that our inability to cure most cancers is the result of their stem cells continuing to thrive and becoming resistant to the drugs that kill their offspring. Dr. Cobbs group has been successful in growing the stem cells that feed a particularly virulent and deadly form of brain tumor, and are testing these cells to determine what kinds of therapies may eliminate them. This year your generous donations helped to advance our collaboration with SNI. We re excited to report that this project is now up and running, and we ve successfully grown breast cancer stem cells using samples from three patients. Many of our breast cancer surgeons at Swedish, particularly Karen J. Hendershott, M.D., have shown a great interest in this work, as it has the potential to dramatically improve how breast cancer is treated. This is a long-term project, but we re excited about the progress we ve made so far. Our ultimate goal is to develop treatments to attack the original malignant cells rather than their offspring, as this could help eradicate drug-resistant clones of cancer. Researching innovative therapies for blood cancers In the area of blood cancers, our team continues to study the development of leukemia and other bone marrow disorders in patients who have received chemotherapy and radiation. Unfortunately, certain cancer treatments can cause some patients to develop leukemia or bone marrow disorders in addition to their primary cancer. This past August we published a paper on this topic in Leukemia Research, an esteemed medical journal read by health care professionals worldwide. Thank you! Thank you for your thoughtful support of the at SCI. Your generosity allows us to remain at the forefront of cancer research and to bring treatments with the best possible outcomes to our patients. We re honored to count you as a partner in this important work, thank you! You can learn more about Dr. Kaplan s research publications at Swedishfoundation.org/kaplan. Thank you for your extraordinary caring.
5 Swedish Cancer Institute Research Initiatives Expand the Frontiers of Cancer Research Evaluating Scientific Wellness in breast cancer survivors Each year, approximately 250,000 women in the United States are diagnosed with invasive breast cancer, while an additional 60,000 women are diagnosed with noninvasive breast cancer. While these numbers are daunting, improvements in breast cancer detection and treatment are helping more women survive this disease. As the number of breast cancer survivors continues to grow, the quality of survivorship for women cured of cancer and for those whose disease remains active is increasingly important. Thanks to projects like The Cancer Genome Atlas and The Human Genome Project, we have a much better understanding of human biology overall and how cancer can affect each person differently. This increase in knowledge and understanding has led physicians and researchers at SCI and our partners at the Institute for Systems Biology (an affiliate of Providence Health & Services, as is Swedish) to develop an approach called Scientific Wellness. This new methodology uses molecular biology to develop expert medical tools to assess and improve wellness among breast cancer survivors. Dr. Kaplan is part of a team that will use Scientific Wellness to explore, and ultimately improve, quality of life for breast cancer survivors. SCI will recruit 100 women with newly diagnosed breast cancer and monitor them with scientific wellness tools before, during and for at least two years following treatment. This monitoring will track various aspects of each woman s unique biologic structure (known as biomarkers), including their hormonal levels, organ and physiologic systems and an analysis of gene mutations related to their cancer. We ll also study the common side effects of treatment including neuro-cognition issues, fatigue, joint pain and gastrointestinal inflammation. Through this study, SCI researchers hope to identify biomarkers that help us better understand how different women react to their cancer and to specific treatments. Similarly, the research team hopes to develop a clearer picture of how specific cancers will react to specific treatments. Both of these points are especially important in the context of increased survivor ship, as they have the potential to help women live healthier lives past treatment.
6 Swedish Cancer Institute Research Initiatives Expand the Frontiers of Cancer Research continued... New Clinical Trials Unit at Swedish First Hill opened in March 2016 Your support of the Kaplan Fund helps advance critical research to improve the health and well-being of patients with cancer. Thanks to you, SCI has one of the most established clinical cancer research programs in the region. In addition to Dr. Kaplan s research activities, SCI is currently participating in 170 clinical trials of new cancer therapies, including many personalized therapy trials. This past March, our research program expanded with the opening of the Robert and Jean Reid Family Innovative Therapeutics & Research Unit (ITU), which was generously funded in part by philanthropic contributions. The Reid ITU is an early-phase clinical trials unit focused on investigational therapies that are driven by SCI s Personalized Medicine Program, which helps match our patients with therapies and investigate key questions about personalized treatment. This state-of-the-art center contains a specialized pharmacy, a supportive care space for our patients and their families, and new treatment rooms that allow our patients to participate in any available clinical trial. SCI s unique model delivers the best of both worlds, bringing together the patient care of a top-ranked medical center and the lifesaving research often found in large university-affiliated hospitals. Because of supporters like you, patients have access to the latest clinical trials and research to help find the best treatments for their cancer. To learn more about these initiatives or to continue your investment in the, please contact: Lauren Moore, CFRE Philanthropy Director, Swedish Cancer Institute or Lauren.Moore@swedish.org 747 Broadway Seattle, WA Foundation@swedish.org Swedishfoundation.org
Thomas C. Wilmot, Sr. Judy Wilmot Linehan
Thomas C. Wilmot, Sr. Judy Wilmot Linehan The Wilmot Family For more than 35 years, the Wilmot family has been dedicated to supporting cancer research and care for the Rochester community. Their generosity
More informationPROGRESS UPDATE. A Kids Brain Tumor Cure Foundation
PROGRESS UPDATE A Kids Brain Tumor Cure Foundation September 2016 EXECUTIVE SUMMARY Primary cancers of the brain have surpassed leukemias to become the number one cause of cancer-related death in children.
More informationHOW TO MAXIMIZE PATIENT RECRUITMENT IN ONCOLOGY TRIALS A BIOPHARMA DIVE PLAYBOOK
HOW TO MAXIMIZE PATIENT RECRUITMENT IN ONCOLOGY TRIALS A BIOPHARMA DIVE PLAYBOOK Over the last several decades, patient recruitment for clinical trials has remained a major barrier to rapid execution of
More informationChapter 5: Epidemiology of MBC Challenges with Population-Based Statistics
Chapter 5: Epidemiology of MBC Challenges with Population-Based Statistics Musa Mayer 1 1 AdvancedBC.org, Abstract To advocate most effectively for a population of patients, they must be accurately described
More informationStewardship Report. Presented to. The Harold E. Eisenberg Foundation
Stewardship Report Presented to The Harold E. Eisenberg Foundation June 2018 Our Appreciation Dear Harold E. Eisenberg Foundation Board Members and Friends, On behalf of the Robert H. Lurie Comprehensive
More informationCancer changes lives, but so do you. How YOU are changing the cancer story
Cancer changes lives, but so do you. How YOU are changing the cancer story Research and Clinical Trials Report to Donors 2017 You ve given the gift of HOPE Hope is at the heart of cancer research. Hope
More informationCANCER 1.7 M 609,000 26% 15.5 M 73% JUST THE FACTS. More Than 1,100 Cancer Treatments in Clinical Testing Offer Hope to Patients
CANCER MEDICINES IN DEVELOPMENT 2018 REPORT JUST THE FACTS MORE THAN 1.7 M ESTIMATED NEW CASES OF CANCER IN 2018 IN THE UNITED STATES MORE THAN 609,000 U.S. CANCER DEATHS ARE EXPECTED IN 2018 SINCE PEAKING
More informationGiving Opportunities Center for Regenerative Medicine $5 million
Beyond Extraordinary Giving Opportunities Name Center for Regenerative Medicine Leukemia Center of Excellence Lymphoma Center of Excellence Multiple Myeloma Center of Excellence The Infusion Treatment
More informationGPS Cancer. For Health Plans and Employers. Precise molecular profiling for informed, personalized cancer treatment strategies MOLECULAR PROFILING
MOLECULAR PROFILING GPS Cancer For Health Plans and Employers Precise molecular profiling for informed, personalized cancer treatment strategies Forward-thinking organizations are covering NantHealth molecular
More informationPartnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC
Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives Oncology Therapeutic Area Janssen Research & Development, LLC The patients are waiting. Dr. Paul Janssen To Our Potential
More information2016 Uterine Cancer Annual Report
2016 Uterine Cancer Annual Report Overview At Carolinas HealthCare System s Levine Cancer Institute, we offer comprehensive care focused on using the latest technology and innovative techniques in the
More informationCITY OF HOPE PROSTATE CANCER OUTCOME SUMMARY
CITY OF HOPE PROSTATE CANCER OUTCOME SUMMARY City of Hope s median survival surpasses SEER LA in Stages I IV Prostate Cancer* Surveillance, Epidemiology, and End Results Program *Based on SEER data from
More informationA World Free From Cancer. BC Cancer Foundation 2011 Report to Donors
A World Free From Cancer BC Cancer Foundation 2011 Report to Donors For the year ended March 31, 2011 Table of Contents Page 3 Page 5 Partners in Discovery A Message from the BC Cancer Foundation Chairman
More informationYour Guide to Prostate Cancer
Your Guide to Prostate Cancer If you face a diagnosis of prostate cancer, what s next? We can help. A prostate cancer diagnosis can be overwhelming. The good news is that while prostate cancer can be serious,
More informationOverview...3. Cancer Program.4. Breast Cancer with 5-year Survival Analysis...6. Systemic Therapy.7. Stage of Breast Cancer Diagnosed in
2011 Annual Report Table Of Contents Overview...3 Cancer Program.4 Breast Cancer with 5-year Survival Analysis...6 Systemic.7 Stage of Breast Cancer Diagnosed in 2008..8 Radiation and Systemic Only...9
More informationPROGRESS UPDATE. Evan T. Mandeville DIPG Research Fund
PROGRESS UPDATE Evan T. Mandeville DIPG Research Fund October 2017 EXECUTIVE SUMMARY Investigators at Dana-Farber Cancer Institute are global leaders in pediatric brain tumor research and patient care,
More informationBreast Cancer Task Force of the Greater Miami Valley A collaborative effort of health care professionals and breast cancer survivors in the Greater
Breast Cancer Task Force of the Greater Miami Valley A collaborative effort of health care professionals and breast cancer survivors in the Greater Dayton Area Last Updated Fall 2014 TABLE OF CONTENTS
More informationHighlights from the 2009 Annual Meeting of the American Society of Clinical Oncology. 20 Combination Treatments for Glioblastoma
BRAIN CANCER 18 Brain Cancer Highlights from the 2009 Annual Meeting of the American Society of Clinical Oncology Edited by Henry S. Friedman, MD Duke University Medical Center Durham, North Carolina 20
More informationFDA APPROVES HERCEPTIN FOR THE ADJUVANT TREATMENT OF HER2-POSITIVE NODE-POSITIVE BREAST CANCER
NEWS RELEASE Media Contact: Kimberly Ocampo (650) 467-0679 Investor Contact: Sue Morris (650) 225-6523 Advocacy Contact: Ajanta Horan (650) 467-1741 FDA APPROVES HERCEPTIN FOR THE ADJUVANT TREATMENT OF
More informationAddressing Breast Cancer's High Recurrence Rates: The Breast Cancer Translational Center of Excellence (TCE)
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/addressing-breast-cancershigh-recurrence-rates-breast-cancer-translational-center-excellence-tce/7981/
More informationMaking a Difference. Highest quality care. Education. Research. Innovation. OUR MISSION:
Making a Difference Highest quality care. Education. Research. Innovation. OUR MISSION: To deliver world-class care on a daily basis to our patients using the most advanced technologies available. To conduct
More informationAn Extraordinary Resource for Cancer Care
An Extraordinary Resource for Cancer Care Anderson Family Cancer Institute The Campaign for Jupiter Medical Center Gaining Critical Mass Against Cancer $50 Million fundraising goal to build our new cancer
More informationREFERENCE CODE GDHC465DFR PUBLICAT ION DATE SEPTEMBER 2014 KADCYLA (HER2-POSITIVE BREAST CANCER) - FORECAST AND MARKET ANALYSIS TO 2023
REFERENCE CODE GDHC465DFR PUBLICAT ION DATE SEPTEMBER 2014 KADCYLA (HER2-POSITIVE BREAST CANCER) - Executive Summary The table below presents the key metrics for Kadcyla for human epidermal growth factor
More informationHistory of Oncology Research at Intermountain Healthcare
History of Oncology Research at Intermountain Healthcare Elizabeth Hale Hammond, MD, FACP Consulltant Pathologist, Intermountain Healthcare, Professor of Pathology, University of Utah School of Medicine;
More informationA report on the Pediatric Low-Grade Astrocytoma (PLGA) Program Prepared for the Lauren s First and Goal Foundation August 6, 2013
A report on the Pediatric Low-Grade Astrocytoma (PLGA) Program Prepared for the Lauren s First and Goal Foundation August 6, 2013 EXECUTIVE SUMMARY Over the past several years, the Pediatric Low Grade
More informationBREAST CANCER SITE STUDY REPORT By Robert O. Maganini, M.D., F.A.C.S. Breast Surgeon, Alexian Brothers Medical Group
BREAST CANCER SITE STUDY REPORT By Robert O. Maganini, M.D., F.A.C.S. Breast Surgeon, Alexian Brothers Medical Group Breast cancer is the most common cancer diagnosed in women around the world. In the
More informationBreastCancerAdvisor by DR. SILVANA MARTINO January 2014
BreastCancerAdvisor by DR. SILVANA MARTINO January 2014 Dear Readers, It is the start of a new year and even as I get a bit older, I still experience great joy at this time. A feeling that there is a new
More informationScreening for Breast Cancer
Understanding Task Force Recommendations Screening for Breast Cancer U.S. Preventive Services Task Force (Task Force) has issued a final recommendation statement on Screening for Breast Cancer. se final
More informationIrish Experts Launch Global Report and Call for Increased Focus on Metastatic Breast Cancer
Irish Experts Launch Global Report and Call for Increased Focus on Metastatic Breast Cancer Early detection does not help survival for metastatic breast cancer patients - average survival for women with
More informationSeattle Cancer Care Alliance Updates, Relaunches Brand Redesigned logo reiterates founding partner strength, patient care commitment
Seattle Cancer Care Alliance Updates, Relaunches Brand Redesigned logo reiterates founding partner strength, patient care commitment SEATTLE (Oct. 6, 2015) Seattle Cancer Care Alliance (SCCA) has grown
More informationSustain and Seize Cancer Research Opportunities
One Voice Against Cancer (OVAC) appreciates the opportunity to submit written comments for the record regarding funding for cancer programs for research, prevention, detection, and treatment as well as
More informationHighlights from the 2009 Annual Meeting of the American Society of Clinical Oncology
BREAST CANCER 24 Breast Cancer Highlights from the 2009 Annual Meeting of the American Society of Clinical Oncology Edited by William J. Gradishar, MD Robert H. Lurie Comprehensive Cancer Center of Northwestern
More informationClaudia Adams Barr Program in Innovative Cancer Research Dana-Farber Cancer Institute BARR PROGRAM IMPACT STATEMENTS
Claudia Adams Barr Program in Innovative Cancer Research Dana-Farber Cancer Institute BARR PROGRAM IMPACT STATEMENTS Brain Cancer New Treatment Opportunities - Discovery of new pathways in brain cancers
More informationSwedish Cancer Institute. Personalized Medicine Program
Swedish Cancer Institute Personalized Medicine Program 0 Transforming Cancer Care through Personalized Treatment Cancer care is at a transformative moment. Conventional treatment methods are being enhanced
More informationFrom the director. Joe V. Selby, MD, MPH
For 50 years, the Division of Research has been a central component in Kaiser Permanente s commitment to be a learning organization, dedicated to understanding and improving the health of Kaiser Permanente
More information2013 ANNUAL CANCER REPORT
213 ANNUAL CANCER REPORT CONTENTS EXECUTIVE SUMMARY 1 CANCER PROGRAM OUTCOMES Cancer Volume for the System 1 Cancer Volume by Hospital Location 2 COMMISSION ON CANCER ACCREDITATION AND THE NATIONAL CANCER
More informationComparative Effectiveness Research (CER) and Personalized Medicine: Policy, Science, and Business
Comparative Effectiveness Research (CER) and Personalized Medicine: How a comprehensive CER system can support personalized medicine Amy P. Abernethy, MD October 28, 2009 CER in Cancer Care? 2 Friends
More informationUC San Diego HIV Institute Creating a Future Without HIV/AIDS
UC San Diego HIV Institute Creating a Future Without HIV/AIDS Executive Summary HIV/AIDS will never cure itself, but at the University of California San Diego and UC San Diego Health, we believe that we
More informationMolecular Imaging and Cancer
Molecular Imaging and Cancer Cancer causes one in every four deaths in the United States, second only to heart disease. According to the U.S. Department of Health and Human Services, more than 512,000
More informationStudy of Triple-Negative Breast Cancer is Most Cited in AACR Journal
MEDIA CONTACT: Craig Civale Craig.Civale@BaylorHealth.edu (817)709-7067 Study of Triple-Negative Breast Cancer is Most Cited in AACR Journal TGen, Baylor, US Oncology study revealed therapeutic drug targets
More informationEARLY DETECTION: THE NEW CANCER PARADIGM
EARLY DETECTION: THE NEW CANCER PARADIGM By Dr. Amit Kumar and Robert A. Berman March 1, 2016 A seemingly healthy patient walks into the doctor s office for a routine checkup. The doctor says, I have good
More informationASCO Publishes "Top Five" List of Opportunities to Improve Quality and Value in Cancer Care
Published on ASCO (https://www.asco.org) Home > ASCO Publishes "Top Five" List of Opportunities to Improve Quality and Value in Cancer Care ASCO Publishes "Top Five" List of Opportunities to Improve Quality
More informationAccelerate Your Research with Conversant Bio
Imagination has given us the steam engine, the telephone, the talkingmachine and the automobile, for these things had to be dreamed of before they became realities. So I believe that dreams... are likely
More informationFast-Forwarding a Cure for Melanoma
Fast-Forwarding a Cure for Melanoma Vision Targeting an Urgent Problem Melanoma often starts out small, misleadingly insignificant a change in a mole, a mark on a fingernail. But the consequences can be
More informationJust the FACTS: You can help! Join the NMDP Registry. Vital Statistics
Just the FACTS: You can help! Join the NMDP Registry Vital Statistics Every year, more than 10,000 men, women and children get life-threatening diseases such as leukemia and lymphoma, and do not have a
More informationUnderstanding Tumor Markers for Breast and Colorectal Cancers. A Patient s Guide. Recommendations of the American Society of Clinical Oncology
Cover Layout 1 A Patient s Guide Understanding Tumor Markers for Breast and Colorectal Cancers Recommendations of the American Society of Clinical Oncology ... Cover Layout 2 A Patient s Guide Understanding
More informationSponsorship Opportunities I AM A RIDER. I AM THE DIFFERENCE. Hosted by. October 29, 2017
Sponsorship Opportunities I AM A RIDER. I AM THE DIFFERENCE. Hosted by October 29, 2017 Be a part of the 2017 Wheel to Survive Houston Wheel to Survive 2017 is Houston s second annual indoor cycling fundraiser
More informationWhat You Need to Know About Ovarian Cancer
What You Need to Know About Ovarian Cancer About Us The Rhode Island Ovarian Cancer Alliance (RIOCA) was formed in honor and memory of Jessica Morris. Jessica was diagnosed with Stage IIIC Ovarian Cancer
More informationDUARTE, Calif. A team of City of Hope researchers has received a two-year, $1
FOR IMMEDIATE RELEASE January 30, 2014 CONTACT H. Chung So / Roberta Nichols Phone: 800-888-5323 hso@coh.org / ronichols@coh.org $1 million Movember-Prostate Cancer Foundation Challenge Award will fund
More informationProgress Update June 2017 Lay Summary Funding: $6,000,000 Grant Funded: July 2015 Dream Team Members Dream Team Leader:
SU2C -Ovarian Cancer Research Fund Alliance-National Ovarian Cancer Coalition Dream Team Translational Research Grant: DNA Repair Therapies for Ovarian Cancer AND SU2C Catalyst Merck-Supported Supplemental
More informationA View to the Future: The Development of Targeted Therapy for Melanoma. Michael Davies, M.D., Ph.D.
A View to the Future: Science to Survivorship Symposium September 26, 2009 The Development of Targeted Therapy for Melanoma Michael Davies, M.D., Ph.D. Assistant Professor, Melanoma Medical Oncology How
More informationCommunity Benefit Strategic Implementation Plan. Better together.
Community Benefit Strategic Implementation Plan 2016 2019 Better together. Table of Contents Introduction... 4 Priority 1: Community Health Infrastructure... 5 Objective 1.1: Focus resources strategically
More informationSU2C TOP SCIENCE ACCOMPLISHMENTS
SU2C TOP SCIENCE ACCOMPLISHMENTS INTRODUCTION Since our founding in 2008, Stand Up To Cancer has funded 87 team science projects, with budgets ranging from $250,000 for a short research project to over
More informationApplications of Proton Therapy for Breast Cancer
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/applications-protontherapy-breast-cancer/7789/
More informationPROGRESS UPDATE. Evan T. Mandeville DIPG Research Fund
PROGRESS UPDATE Evan T. Mandeville DIPG Research Fund December 2018 EXECUTIVE SUMMARY As a top-ranked pediatric cancer center, Dana-Farber Cancer Institute combines first-rate patient care with groundbreaking
More informationHello and welcome to Patient Power sponsored by Northwestern Memorial Hospital. I'm Andrew Schorr.
Brain Tumor Clinical Trials Webcast November 22, 2011 Sean Grimm, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of Northwestern Memorial Hospital, its medical
More informationOncology 101. Cancer Basics
Oncology 101 Cancer Basics What Will You Learn? What is Cancer and How Does It Develop? Cancer Diagnosis and Staging Cancer Treatment What is Cancer? Cancer is a group of more than 100 different diseases
More informationThe Lung Cancer Network: Collaborate to Cure
The Lung Cancer Network: Collaborate to Cure The Gala Wednesday, June 6, 2018 Opportunities for Support Everything You Need to Know About the 2018 Gala World-class collaboration. Join us on June 6, 2018
More information2009 Annual Report Alvin & Lois Lapidus Cancer Institute LifeBridge Health
2009 Annual Report Alvin & Lois Lapidus Cancer Institute LifeBridge Health Dear Collegues, The Alvin and Lois Lapidus Cancer Center is proud of its reputation as a Cancer Center that has gained community,
More informationDONOR RECOGNITION PROGRAM
DONOR RECOGNITION PROGRAM HARLEY S ANGELS CRUIZIN TO CURE Mission Statement The Mission of Harley's Angels is to promote breast cancer awareness, education, and support of research for the prevention and
More informationTHE RIGHT PARTNER CAN MAKE A DIFFERENCE
THE RIGHT PARTNER CAN MAKE A DIFFERENCE HOAG FAMILY CANCER INSTITUTE PROGRESSIVE CANCER CARE FOR THE COMMUNITY Since 1990, Hoag Family Cancer Institute has been providing leading- edge cancer care in
More informationRestoration. JDRF is turning Type One into Type None. attack so the newly restored beta cell function is protected.
Restoration JDRF is turning Type One into Type None Type 1 diabetes (T1D) is an extraordinarily complex disease. Finding the cure a short-term clinical intervention, with minimal side effects, after which
More informationBreast Cancer Survivor Treatment Summary and Plan
Breast Cancer Survivor Treatment Summary and Plan The attached Breast Cancer Survivor Treatment Summary and Plan is a form that will summarize your cancer diagnosis and treatment. It will help you plan
More informationMeeting California s Cancer Challenges. UC Cancer Consortium
Meeting California s Cancer Challenges UC Cancer Consortium 2017 Despite steady declines in cancer rates over the past 20 years, cancer is soon expected to overtake heart disease as California s leading
More information2016 Oncology Institute Annual Report
2016 Oncology Institute Annual Report Message from the Cancer Committee: On behalf of the Cancer Committee of The Methodist Hospitals, we are pleased to present to you our 2016 Oncology Institute Annual
More informationMr. Kevin Dwan. The Sabrina Foundation Center for Cardiovascular Health in Pregnancy
A Proposal to Mr. Kevin Dwan For support of The Sabrina Foundation Center for Cardiovascular Health in Pregnancy A Proposal for the Support of The Sabrina Foundation Center for Cardiovascular Health in
More informationLEVINE CANCER INSTITUTE. Brand Articulation and Messaging Platform
LEVINE CANCER INSTITUTE Brand Articulation and Messaging Platform CONTENTS: Overview/Rationale X Potential Core Brand Values X Brand Attributes X Brand Personality X Brand Positions X The primary purpose
More informationThe Intermountain Oncology Clinical Program: Present and Future
The Intermountain Oncology Clinical Program: Present and Future William T. Sause, MD Director of Radiation Oncology; Intermountain Healthcare; Murray, Utah Objectives: Define current status of the Cancer
More informationWhat is ovarian cancer?
What is ovarian cancer? Ovarian cancer is a type of cancer that forms in tissues of the ovary. Most ovarian cancers are either ovarian epithelial cancers (cancer that begins in the cells on the surface
More informationOncotype DX testing in node-positive disease
Should gene array assays be routinely used in node positive disease? Yes Christy A. Russell, MD University of Southern California Oncotype DX testing in node-positive disease 1 Validity of the Oncotype
More informationLeading-edge cancer treatment + compassionate care
CARE + COVERAGE ˡ NORTHERN CALIFORNIA Leading-edge cancer treatment + compassionate care Working together to bring you hope and healing When you hear the word cancer, it can be a frightening, confusing
More informationWhat is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine
What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine What is Cancer? Layman s terms: cancer starts when cells grow out of control (in any place in the body) and crowd out normal cells
More informationGynecologic Cancer French Hospital Medical Center Cancer Committee Public Report
Table of Contents: PAGE 1 Community Cancer Center Program at French Hospital Medical Center PAGE 2 Gynecologic Oncology Program on the Central Coast PAGE 3 Gynecologic Cancer Basic Facts and Risk Factors
More informationCommunity Comprehensive Cancer Program at Swedish Covenant Hospital 2009 Annual Report reflecting 2008 statistical data
Community Comprehensive Cancer Program at Swedish Covenant Hospital 2009 Annual Report reflecting 2008 statistical data Chairman s Message K. Joseph Philip, MD Section head, Medical Oncology/Hematology
More informationAIDS Action Committee & Fenway Health
AIDS Action Committee & Fenway Health A New Vision for HIV/AIDS Services and Advocacy Photo: Courtesy of AIDS Action Committee By Peter Kramer, Nonprofit Finance Fund Nonprofit Mergers That Made a Difference
More informationPROGRESS UPDATE. The Pan-Mass Challenge
PROGRESS UPDATE The Pan-Mass Challenge Fall 2017 PAN-MASS CHALLENGE: HITTING A HIGHER GEAR IN THE FIGHT AGAINST CANCER For nearly four decades, the Pan-Mass Challenge (PMC) and Dana- Farber Cancer Institute
More informationStrategic Direction. At The Kids Cancer Project our vision is to find a cure for kids cancer
2016-2018 Strategic Direction At The Kids Cancer Project our vision is to find a cure for kids cancer Our commitment Through the power of science, The Kids Cancer Project is at the forefront fighting for
More informationInformation. about cancer
1 Information about cancer This chapter may help you answer simple questions about what cancer is and how it is treated. There are more than 200 different types of cancer and a range of treatments. Being
More informationCONNECTING ABUNDANCE WITH NEED 2018 REPORT TO THE COMMUNITY
CONNECTING ABUNDANCE WITH NEED 2018 REPORT TO THE COMMUNITY The Dispensary of Hope has a mission to ensure a consistent supply of essential medication to low-income, uninsured people. To accomplish our
More informationScience Report ADVANCES IN CANCER RESEARCH
Science Report ADVANCES IN CANCER RESEARCH Created by Huntsman Cancer Institute s Office of Communications 2016 www.huntsmancancer.org OUR TIME BEGAN with an empty lot and a dream full of promise, determination,
More informationGeorgia Cancer Quality Information Exchange
Georgia Cancer Quality Information Exchange Measuring Progress, Motivating Change William J. Todd President & Chief Executive Officer October 5, 2009 Hamilton Jordan 1944 2008 Georgia Cancer Coalition
More informationResearch. A Reason for Hope.
Research. A Reason for Hope. Pediatric hydrocephalus alone represents 40,000 annual hospital admissions, 2 433,000 hospital days and $2B worth of hospital charges. 3 Today s Reality Hydrocephalus (h dr
More informationWellness Along the Cancer Journey: Cancer Types Revised October 2015 Chapter 2: Breast Cancer
Wellness Along the Cancer Journey: Cancer Types Revised October 2015 Chapter 2: Breast Cancer Cancer Types Rev. 10.20.15 Page 19 Breast Cancer Group Discussion True False Not Sure 1. Breast cancer is not
More informationIMMUNOTHERAPY FOR LUNG CANCER
IMMUNOTHERAPY FOR LUNG CANCER Patient and Caregiver Guide IMMUNOTHERAPY FOR LUNG CANCER Patient and Caregiver Guide TABLE OF CONTENTS Lung Cancer Basics... 2 Immunotherapy... 3 FDA Approved Immunotherapies...
More informationWith your help, our goal is to protect millions more against serious illness through the development of new vaccines and other preventions.
Millions of children are alive, healthy, and have grown to productive adulthood because of what our scientists have taught the world through research. The Hib vaccine alone has saved more than 660,000
More informationTo Benefit the Melanoma Research Alliance
To Benefit the Melanoma Research Alliance Chaired by: Brendan Dillon of UBS, Lee Grinberg of Elliott Management, George Mueller of KKR, AJ Murphy of BAML, Geoff Oltmans of Silver Lake, Jeff Rowbottom of
More informationBLOOD AND LYMPH CANCERS
BLOOD AND LYMPH CANCERS 2 Blood and Lymph Cancers Highlights from the 2009 Annual Meeting of the American Society of Clinical Oncology Edited by Kenneth C. Anderson, MD Harvard Medical School and Dana-Farber
More informationTreatment of 200 Locally Advanced (Stage III) Pancreatic Adenocarcinoma Patients with Irreversible Electroporation: Safety and Efficacy
The following three articles refer to the same April 2015 ASA presentation, and the same research. But, more data is offered in the third article. Treatment of 200 Locally Advanced (Stage III) Pancreatic
More informationBuilding a Personalized. Medicine Program. Title & Subtitle can knockout of image. 22 September October 2015 OI
Building a Personalized Title & Subtitle can knockout of image Medicine Program 22 www.accc-cancer.org September October 2015 OI BY THOMAS D. BROWN, MD, MBA s a non-university research program based in
More informationPPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM
HEMATOLOGY ONCOLOGY PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM COMMITTED TO ADVANCING DRUG DEVELOPMENT IN ONCOLOGY $ MARKETPLACE COMPLEXITIES increasingly competitive marketplace and rising cost pressures
More informationUnited Nations General Assembly June 8, 2011
Remarks by Dr. Mathilde Krim United Nations General Assembly June 8, 2011 I am Mathilde Krim, the Founding Chairman of amfar, The Foundation for AIDS Research. This is a not-for-profit foundation based
More information28 OI November December A Medical Home for Adolescents and Young Adults with Cancer
28 OI November December 2013 www.accc-cancer.org A Medical Home for Adolescents and Young Adults with Cancer By Douglas S. Hawkins, MD Our team consists of more than 30 doctors specializing in cancers
More informationAcute: Symptoms that start and worsen quickly but do not last over a long period of time.
Cancer Glossary Acute: Symptoms that start and worsen quickly but do not last over a long period of time. Adjuvant therapy: Treatment given after the main treatment. It usually refers to chemotherapy,
More informationCANADIAN DIABETES ASSOCIATION
CANADIAN DIABETES ASSOCIATION Submission to the PREMIER S CONVERSATION ON HEALTH July 2007 Canadian Diabetes Association 360 1385 West 8 th Avenue Vancouver, BC V6H 3V9 Phone: (604) 732-1331 Fax: 604-732-8444
More informationSummary of the BreastScreen Aotearoa Mortality Evaluation
Summary of the BreastScreen Aotearoa Mortality Evaluation 1999 2011 Released 2015 nsu.govt.nz Citation: Ministry of Health. 2015. Summary of the BreastScreen Aotearoa Mortality Evaluation 1999 2011. Wellington:
More informationSUSAN G. KOMEN NORTHEAST LOUISIANA EXECUTIVE SUMMARY
SUSAN G. KOMEN NORTHEAST LOUISIANA EXECUTIVE SUMMARY Acknowledgments The Community Profile Report could not have been accomplished without the exceptional work, effort, time and commitment from many people
More informationBreast Cancer: Who Gets It? Who Survives? The Latest Information
Breast Cancer: Who Gets It? Who Survives? The Latest Information James J. Stark, MD, FACP Medical Director, Cancer Program and Director of Palliative Care Maryview Medical Center Professor of Medicine
More informationFine-Tuning Immunotherapy to Treat Prostate Cancer Recorded on: April 24, 2013
Fine-Tuning Immunotherapy to Treat Prostate Cancer Recorded on: April 24, 2013 John Corman, M.D. Medical Director, Floyd & Delores Jones Cancer Institute at Virginia Mason Virginia Mason Medical Center
More informationCamel Milk and Cancer: A Possible Cure?
Camel Milk and Cancer: A Possible Cure? You may have heard that camel milk has many amazing therapeutic benefits, but did you know that it also has anti-cancer properties? In 2016 it was estimated that
More informationViiV Healthcare s Position on Continuous Innovation in Prevention, Testing, Treatment & Care of HIV
ViiV Healthcare s Position on Continuous Innovation in Prevention, Testing, Treatment & Care of HIV ViiV Healthcare is a company 100% committed to HIV, and we are always looking to move beyond the status
More information